Navinta Llc Company Profile
What is the competitive landscape for NAVINTA LLC
NAVINTA LLC has twenty-one approved drugs.
Summary for Navinta Llc
| US Patents: | 0 |
| Tradenames: | 20 |
| Ingredients: | 20 |
| NDAs: | 21 |
| Patent Litigation for Navinta Llc: | See patent lawsuits for Navinta Llc |
Drugs and US Patents for Navinta Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Navinta Llc | MARAVIROC | maraviroc | TABLET;ORAL | 217880-001 | May 13, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | INJECTABLE;INJECTION | 202938-001 | Mar 28, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | INDOMETHACIN SODIUM | indomethacin sodium | INJECTABLE;INJECTION | 206561-001 | Jul 19, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Navinta Llc | FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 078537-001 | Mar 6, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 210179-001 | Sep 11, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | MIGLUSTAT | miglustat | CAPSULE;ORAL | 219111-001 | Mar 14, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

